POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS (POST-ET MF)

Clinical trials for POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS (POST-ET MF) explained in plain language.

Never miss a new study

Get alerted when new POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS (POST-ET MF) trials appear

Sign up with your email to follow new studies for POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS (POST-ET MF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Massive 5,000-Person study launches to map the journey of rare blood cancers

Knowledge-focused Recruiting now

This is a long-term observational study aiming to better understand a group of rare, chronic blood cancers called myeloproliferative neoplasms (MPNs). It will follow 5,000 adults in the U.S. who have been diagnosed with an MPN for at least five years, collecting information from …

Matched conditions: POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS (POST-ET MF)

Sponsor: MPN Research Foundation • Aim: Knowledge-focused

Last updated Mar 18, 2026 14:40 UTC

POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS (POST-ET MF)

Get alerted when new POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS (POST-ET MF) trials appear

Massive 5,000-Person study launches to map the journey of rare blood cancers